Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

Clinical trial NCT06492395 · RECRUITING

Trial details

NCT number: NCT06492395
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-resectable

Start date: 2024-08-01
Primary completion: 2026-07-31
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.